PhaseRx, Inc.
PZRXQ · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|
| Market Cap | $12 | $40 | $30 |
| - Cash | $10 | $3 | $2 |
| + Debt | $6 | $20 | $13 |
| Enterprise Value | $7 | $56 | $40 |
| Revenue | $0 | $0 | $1 |
| % Growth | -100% | -68.8% | – |
| Gross Profit | $0 | $0 | $1 |
| % Margin | – | 100% | 100% |
| EBITDA | -$18 | -$5 | -$5 |
| % Margin | – | -1,439.2% | -414.2% |
| Net Income | -$20 | -$7 | -$7 |
| % Margin | – | -1,967.2% | -570.8% |
| EPS Diluted | -2.68 | -0.94 | -1.16 |
| % Growth | -185.1% | 19% | – |
| Operating Cash Flow | -$10 | -$6 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$6 | -$5 |